Alexander Maxwell
Value, growth, long-term horizon, biotech

IntelGenx Technologies: A Small Cap Company With The Potential For Significant Gains

(Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.)

Within the pharmaceutical sector it can be very hard to find a company that has the potential to grow substantially over the next few years. Often, investors shy away from the pharmaceutical sector simply because of the risks involved: from FDA decisions, to the launch of a product, the sector is fraught with risk. However, for those investors who are willing to take a chance, there is also the potential for significant gains. One particular company with a large amount of potential is IntelGenx Technologies (OTCQX:IGXT...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details